Macrophage inflammatory protein 1 ot (MIP-lot) is a 6-8-kD, lipopolysaccharide-indudble monocyte and neutrophil chemotactic protein that may be important in acute and chronic inflammation. The present study determined the sequential production, source, and in vivo contribution of murine MIP-lot in synchronized Schistosoma mansoni egg pulmonary granuloma formation. Granulomas were examined under conditions of primary, secondary vigorous, and secondary immunomodulated immunity. Secreted MIP-lot was measured in 24-h supernatants from intact granulomas (700/ml) cultured with or without soluble egg antigen (SEA). Primary granulomas isolated from naive mice over a 16-d period showed low spontaneous MIP-lcr production (<1 ng/ml). However, when primary granulomas were challenged with SEA, significant MIP-lot production was observed beginning at day 4 and peaking at day 16. Intact vigorous (isolated from 8-wk-infected mice) and modulated (isolated from 20-wk-infected mice) secondary pulmonary granulomas demonstrated comparable spontaneous MIP-lcr production. Addition of SEA to vigorous stage granulomas augmented expression of MIP-lot at all time points, whereas stimulated modulated stage granulomas did not increase production. The latter observation is likely related to endogenous immunoregulatory mechanisms reported for modulated stage animals. Immunohistochemical localization of MIP-lot in granuloma sections and cytocentrifuge preparations from vigorous lesions localized MIP-lot production to macrophages within granulomas. Treatment of mice with rabbit anti-mouse MIP-lot antibodies significantly decreased 8-d primary granuloma formation (>40%) when compared with control mice. Anti-MIP-lc~ sera also decreased vigorous (>20%), but not modulated granuloma formation. These findings demonstrate that MIP-lot contributes to cellular recruitment during schistosome egg granuloma formation.
T he recruitment of cells into an area of inflammation is a crucial step in the development of delayed-type hypersensitivity responses. Presumably, the secretion ofchemokines contributes to the inflammatory response and is pertinent to the elicitation of cells into the affected area. One cytokine that may be responsible for the recruitment of both neutrophils and monocytes/macrophages to sites of inflammation is macrophage inflammatory protein-1 (MIP-1) 1 (1, 2) . Native MIP-1 is an LPS-inducible, heparin-binding protein made up of two 8-kD peptides, designated MIP-lot and -18, and is a member of the C-C chemokine supergene family (1) (2) (3) . In vivo, the injection of the doublet can induce an acute inflammatory response and prostaglandin-independent fever (2, 4) .
It is interesting that MIP-1 has been found to induce the production of other inflammatory cytokines, TNF-ot, IL-1, and IL-6 (5) .
Granuloma formation during murine schistosomiasis mansoni can be studied under conditions of primary, secondary vigorous, and secondary modulated immunity (6) . During initial egg deposition (5-6 wk of infection), a primary granuloma forms around eggs in response to the foreign body and released soluble egg antigens (SEA) (6, 7) . The continuous deposition of eggs sensitizes the host, and, subsequently, there is a more rapid secondary (vigorous) response which sequesters the deposited egg. Vigorous granuloma formation occurs at 8 wk of infection and accompanies peak production of inflammatory cytokines (8) (9) (10) . As the infection progresses, the intensity of the response wanes and there is onset of modulated granuloma formation associated with impaired cytokine production by 20 wk (8) (9) (10) (11) (12) (13) (14) (15) . The formation of schistosome egg-induced granulomas involves several stages of development (8, 16) . First, there is an early recruitment stage followed by a maintenance or sustenance stage, which presumably continues until the destruction of the egg nidus. Finally, there is a resolution stage manifested by healing and fibrosis. The early cellular recruitment stage is critical for the development of the granuloma and likely requires the generation of chemokines for the elicitation of the leukocytic infiltrate. The maintenance phase would also require the generation of chemokines, necessary for the continued recruitment of cells and sustenance of the granuloma. The cytokines produced during early stages of granuloma formation may be important in the initiation of granuloma development and determine the severity of the associated tissue damage. The characterization of cytokines responsible for the recruitment of inflammatory cells that comprise the granuloma is essential for elucidation of the critical mechanisms that establish those lesions.
In the present study, we have determined the temporal expression of MIP-lol during primary and secondary S. mansoni egg granuloma formation. Immunohistochemical localization of MIP-lo~ has identified the macrophage as the primary source of MIP-lo~ in the developing granuloma. Finally, in vivo neutralization of MIP-loe demonstrated the contribution of this chemokine in the formation of the granuloma during both the primary and vigorous secondary response, but not the modulated secondary response.
Materials and Methods
Animals and Infection. Female CBA/J mice were purchased from the Jackson Laboratory, (Bar Harbor, ME) and were maintained under standard pathogen-free conditions. 5-8-wk-old mice were infected by percutaneous tail infection with 25-30 Peurto Rican strain of Schistosoma mansoni cercariae.
Induction, Isolation, and Culture of Synchronous Pulmonary Granulomas. Synchronous granulomas were induced by i.v. injection of 3,000 isolated S. mansoni eggs into normal and acutely and chronically infected mice. Eggs trapped in the lung elicit a synchronous granulomatous response indicative of that observed within the liver of infected mice. Granulomas were isolated from mice 1, 2, 4, 8, or 16 d after embolization. Mice were killed, lungs were lavaged, inflated with cold R.PMI (Gibco BRL, Gaithersburg, MD) culture media, and homogenized in a blender (Waring, New Hartford, CT). Granulomas were collected over a stainless steel mesh. The granulomas were cultured at 700 lesions/ml in RPMI 1640 supplemented with 10% FCS, 100 mM glutamine, 100 U/ml penicillin, and 100/~g/ml streptomycin in 60-mm culture dishes in the presence or absence of SEA (10/~g/ml). Culture supernatants were collected 24 h after stimulation and stored at -80~ until tested.
Isolated hepatic granuloma cells were obtained from livers of 8-wk-infected mice as previously described (15) . The cells were incubated with SEA for 24 h. Nonadherent cells were then cytocentrifuged and both adherent and nonadherent cells were used in immunohistochemical staining to localize MIP-lcz using the rabbit anti-murine antibodies.
Isolation and RT-PCR Amplification of Whole-lung mRNA. Whole lungs containing synchronous granulomas at different days of development were snap-frozen in liquid nitrogen and stored at -70~ Total cellular RNA from the frozen lungs was isolated by homogenating the lungs with a tissue homogenizer in a solution containing 25 mM Tris, pH 8.0, 4.2 M guanidine isothiocynate, 0.5% sarkosyl, and 0.1 M 2-ME. After homogenation, the suspension was added to a solution containing an equal volume of 100 mM Tris, pH 8.0, 10 mM EDTA, and 1.0% SDS. The mixture was then extracted two times each with phenol-chloroform and chloroform-isoamyl alcohol. The RNA was alcohol precipitated and the pellet dissolved in DEPC water. Total RNA was determined by spectrometric analysis at 260 nm wavelength. 5/,g of total RNA was reversed transcribed into cDNA utilizing an RT kit (GIBCO-BRL) and oligo (dT)n-ls primers. The cDNA was then amplified using specific primers for ~-actin as a control and murine MIP-lcz. The primers used were 5'-GTG-GGG-CGC-CCC-AGG-CAC-CA-3' and 5'-GCT-CGG-CCG-TC, C~TGC~TGA-AGC-3' for fl-actin and 5'-GCC-CTT-GCT-GTT-CTT-CTC-TGT-3' and 5'-GGC-AAT-CAG-TTC-CAG-GTC-AGT-Y for routine MIP-loe, giving amplified products of ~550 and 300 bp, respectively. The amplification buffer contained 50 mM KC1, 10 mM Tris-HCL (pH 8.3), and 2.5 mM MgC1. Specific oligonucleotide primer was added (200 ngAample) to the buffer, along with 1/zl of the reversetranscribed cDNA samples. The cDNA was amplified after determining the optimal number of cycles. The mixture was first incubated for 5 min at 94~ and then cycled 27 times at 95~ for 30 s, 58~ for 45 s, and elongated at 72~ for 75 s. This format allowed optimal amplification with little or no nonspecific amplification of contaminating DNA. After amplification, the sample (20/~1) was separated on a 2% agarose gel containing 0.3/zg/ml (0.003%) of ethidium bromide, and bands visualized and photographed using UV transillumination.
Production of Anti-MIP-lol Antibodies. Rabbit anti-murine MIPlc~ antibodies were prepared by multiple-site immunization of New Zealand White rabbits with recombinant murine MIP-lcx (R&D Systems, Inc., Minneapolis, MN) in CFA. Polyclonal antibodies were titered by direct ELISA and specificity verified by the failure to crossreact with mlL-lc~, mi1r mTNF, Ib6, mJE, mMIP-I~, hMCP-1, hlL-8, hRANTES, hMIP-lcz, and hMIP-1B. The polyclonal antibodies neutralized routine MIP-l~x-induced monocyte chemotaxis in vitro and were used for immunohistochemical localization of murine MIP-lc~ in granulomas and in vivo neutralization of MIP-loL experiments. Furthermore, the IgG fraction of the serum was purified over a protein A column and used in a sandwich ELISA as previously described.
MIP-lol ELISA. Extracellular immunoreactive MIP-lcz was quantitated using a modification of a double ligand method as previously described (17) . Briefly, flat-bottomed 96-well microtiter plates (Immuno-Plate I 96-F; Nunc, Roskilde, Denmark) were coated with 50/zl/well of rabbit anti-MIP-lcz antibody (1 ng//zl in 0.6 M NaC1, 0.26 M H3BO4, and 0.08 N NaOH, pH 9.6) for 16 h at 4~ and then washed with PBS, pH 7.5, 0.05% Tween 20 (wash buffer). Microtiter plate nonspecific binding sites were blocked with 2% BSA in PBS and incubated for 90 min at 37~ Plates were rinsed four times with wash buffer, and diluted (1:2 and 1:10) cell-free supernatants in duplicate were added, followed by incubation for 1 h at 37~ Plates were washed four times, followed by the addition of 50/zl/well biotinylated rabbit anti-MIPlcx antibody (3.5 ng/t~l in PBS, pH 7.5, 0.05% Tween 20, and 2% FCS), and plates incubated for 30 min at 370C. Plates were washed four times, streptavidin-peroxidase conjugate (Bio-Rad Laboratories, Richmond, CA) added, and the plates incubated for 30 rain at 37~ Plates were again washed four times and chromogen substrate (Bio-Rad Laboratories) added. The plates' reaction terminated with 50/~l/well of 3 M H2SO4 solution. Plates were read at 490 nm in an ELISA reader. Standards were one-half log dilutions of recombinant MIP-la from 1 pg/ml to 100 ng/ml. This ELISA method consistently detected MIP-la concentrations above 10 pg/ml.
Imraunohistockemical Localization of MIP-l c~ in Synchonous Granulomas. Paraffin-embedded tissue sections mounted on poly-L-lysine slides were deparaffinized with xylene followed by stepwise rehydration in 100, 95, 70, and 50% ethanol followed by 10 min incubation in PBS. Cytospin preparations of dispersed granulomas were fixed with 4% paraformaldehyde and treated in a similar fashion to the tissue sections. All sections and fixed calls were blocked with normal goat serum for 30 rain. The sections were covered with the rabbit anti-murine MIP-lc~ serum diluted in PBS (1:250) for 30 rain at 37~ After rinsing three times with PBS, the sections were overlaid for 20 rain with biotinylated goat anti-rabbit IgG (supersensitive reagent 1:10; BioGenex Laboratories, San Ramon, CA). After rinsing three times with PBS, the lung sections were incubated for 20 min with streptavidin-atkaline phosphatase (1:20; BioGenex) at 37~ The slides were rinsed with PBS and overlaid with Fast red (BioGenex Laboratories) until color development was observed (15-30 rain). Sections were rinsed and counterstained with Mayer's hemotoxylin (Mayer & Myles Laboratories, Coopersburg, pA).
Inhibition of In Vivo Granuloma Formation with Anti-MIP-lot
Serum. Pulmonary granuloma formation was observed after challenge with S. mansoni eggs in naive, 8-wk and 20-wk-infected mice after treatment with rabbit anti-routine MIP-lc~ or normal rabbit serum. Mice were pretreated and then treated every other day with 0.5 ml of serum intraperitoneally for 8 d with the primary and 4 d with vigorous and modulated secondary granuloma formation. After 8 or 4 d, respectively, the lungs were inflated and preserved in 10% buffered formalin. Histological sections were stained and granulomas were measured with computer-assisted morphometric analysis. Each group contained five to six mice, and 20 granulomas from each lung were measured.
Statistics. Statistical significance was determined by Student's t test and significance was determined with P values <0.05.
Results

RT-PCR Amplification of MIP-lcr from Pulmonary Granulomas.
We first screened granulomatous lungs for MIP-lo~ mRNA by isolating whole RNA at different stages of granuloma development and performing RT followed by primerdirected PCR amplification. Fig. 1 illustrates that MIP-lot m R N A can be detected at most points of primary and secondary granuloma formation. Low signal levels were even detected in normal lungs. During primary granuloma formation, MIP-loe mRNA levels were equal to or slightly greater than that of the normal control lungs throughout the time frame studied (days 1-16). During secondary vigorous granuloma formation, significantly more mRNA was detected throughout the development period and as early as 12 h post-egg embolization. MIP-lo~ mKNA during secondary modulated granuloma formation was also upregulated by 12 h, but decreased at 1, 2, and 4 d with mRNA appearing again at days 8 and 16. These results suggested that MIP-lot is differentially expressed during the primary, secondary vigorous, and secondary modulated response.
MIP-Icr Production frora In Vitro Cultured Granulomas. We next directly measured sequential production of MIP-lo~ by egg granulomas isolated from the lungs of normal mice or mice at 8 (vigorous) and 20 (modulated) wk of infection. Granulomas were collected at 1, 2, 4, 8, and 16 d post-egg challenge and were incubated in culture in the presence or absence of SEA (5/~g/ml) for 24 h. The time course study showed a significant increase in antigen-dicited production of MIP-lol as the primary granuloma developed from 4 to 16 d (3.7 + 0.6 to 25.9 _+ 16 ng/ml, respectively) (Fig. 2) . Antigen-dicited production of MIP-lc~ was not detected before day 4.
A different pattern of MIP-lcx production was observed during the vigorous and modulated secondary response (Fig.  3) . In the absence of SEA, both vigorous and modulated granulomas produced comparable background levels of MIP-lc~ ranging from 2.0 to 7,8 ng/ml. However, SEA stimulation revealed a dear difference between the groups. SEA augmented production of MIP-lc~ only in the vigorous granuloma cultures. The modulated granulomas failed to show augmentation of MIP-lc~ production with addition of SEA. Compared with the primary response, the vigorous granuloma MIP-lo~ production was accelerated peaking at day 2 (16 _+ 4.6 ng/ml) and only partially declining at days 4 and 8 (10.5 + 4.7 and 8.1 + 2.5 ng/ml, respectively). Modulated granulomas also showed an accelerated onset of MIP-loL production, but levels were consistently lower then those for vigorous lesions. Thus, MIP-lc~ production showed a direct correlation with the rate and amplitude of granuloma formation.
Imraunohistochemical Localization of MIP-I cr Production in Egg Granulomas.
To identify potential sites of MIP-loe production, sections of paraffin-embedded granulomatous tissue from normal and schistosome-infected mice were stained for MIPlol immunohistochemically. As shown in Fig. 4 , MIP-lc~ is localized to mononudear cells in granulomas. These studies Figure 2 . MIP-I~ production by isolated primary pulmonary granulomas. Isolated pulmonary granulomas (700/ml) from naive mice at various points of development were cultured for 24 h with or without SEA. Culture supernatants were collected and the level of MIP-I~ was measured by ELISA. Data represents the mean + SEM of three separate experiments using different mice and separate egg harvests. demonstrated a greater number of cells stained positive in vigorous lesions (Fig. 4, A and B) than in either the primary or secondary modulated granulomas (data not shown). To further clarify the specific cell population that was producing MIP-lot, vigorous (8-wk) granulomas were isolated and dispersed. The dispersed whole or macrophage-depleted (by plastic adherence) granulomas cells were incubated with SEA. Immunohistochemical localization of MIP-lot was then per- Figure 3 . MIP-I~ production by isolated secondary vigorous and modulated pulmonary granulomas. Isolated pulmonary granulomas (700/ml) from S. mansoni-infected mice at various points of development were cultured for 24 h with or without SEA. Culture supernatants were collected and the level of MIP-l~ was measured by ELISA. Data represents the mean _+ SEM of three separate experiments using different mice and separate egg harvests.
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formed on cytospin specimens of adherent and nonadherent cell populations. In all cases, the only cells that expressed MIPlot was the macrophage population (Fig. 5, A-C) . In addition, extracellular MIP-lot was detected in cultures of unseparated secondary vigorous granuloma cells but not macrophage-depleted cultures (1.2 ng/ml and <0.1 ng/ml, respectively). Taken together, these studies indicate that the macrophage was the primary cellular source of MIP-lc~ in the granuloma.
Inhibition of Pulmonary Egg Granulomas by Anti-MIP-Icr Antisera. To determine whether or not MIP-lot contributed
to granuloma development, we performed in vivo neutralization studies with polyclonal rabbit anti-mouse MIP-lot serum. Primary granulomas were initiated in naive mice treated with anti-MIP-lot or control serum every other day. At 8 d, mice were killed and the lungs were examined histologically. As shown in Fig. 6 , morphometric assessment of granuloma development demonstrated that anti-MIP-lo~ treatment attenuated granuloma formation by more than 40% (P < 0.001) as compared with controls (8,156 +_ 587/xm 2 and 13,461 _+ 832 #m 2, respectively). A representative photomicrograph (Fig. 7, A and B) demonstrates the abrogation due to in vivo neutralization of MIP-lot in primary granuloma formation. In many lesions, nearly all of the cellular infiltration was inhibited by the anti-MIP-lot treatment.
We next determined whether anti-MIP-lot serum treatment could affect secondary vigorous and modulated granuloma formation. In these studies, animals were treated with anti-MIP-lot serum at days 0 and 2, then killed at day 4. Depletion of MIP-lo~ significantly (P < 0.01) attenuated vigorous granuloma area by >20% as compared with controls (24,574 _ 1,249 #m 2 and 30,660 _+ 932/~m 2, respectively) (Fig. 6) . In contrast, neutralization of MIP-lot in modulated granuloma formation failed to have a significant effect on granuloma size as compared with infected control mice (17,997 _+ 910 #m 2 and 18,709 + 932/zm 2, respectively). lustrates that the degree of abrogated recruitment with vigorous lesions (C and D) was not as great as in primary granuloma formation, and no decrease was evident at the modulated stage of infection (E and F).
Discussion
In the present study, we have demonstrated the temporal expression, cellular source, and the in vivo contribution of MIP-lo~ in the development of pulmonary S. mansoni egg-induced granulomas. The expression of MIP-lo~ during the course of primary and secondary granuloma formation corresponded to the immune status of the host. The primary granuloma, which peaks in size at 8 to 16 d after embolization (6, 16) , began expressing detectable MIP-lo~ at day 4 and continued to increase through day 16. The constitutive levels of MIP-lc~ were much higher in the secondary vigorous and modulated granulomas as compared with the primary granulomas. The constitutive levels of MIP-lot in the secondary response may reflect a primed environment for the rapid expression of MIP-lc~ and recruitment of cells for accderated granuloma formation around the deposited egg. The in vitro expression of MIP-lo~ by isolated vigorous granulomas was accelerated in response to SEA, detectable at day 1, and peaking at day 2, with levels largely sustained at days 4 and 8. It is interesting that the modulated granulomas expressed background levels of MIP-lot comparable with the vigorous stage granulomas, however, upon stimulation with SEA, there was increased population of MIP-lc~ only at day 1. In general, the in vitro production of SEA-specific MIPlo~ corresponded directly to the level of MIP-lot-specific mKNA as determined by RT-PCR. The decreased production of MIP-lc~ at the modulated stage of infection corresponds to previous reports demonstrating decreased T cell function and lymphokine production (6, 8, (11) (12) (13) (14) (15) . These findings, along with the antigen-specific increases in MIPlc~ at the vigorous stages in the present study would suggest that this cytokine is regulated in conjunction with or by T lymphocytes and their products. Lack of antigen-elicited MIPlc~ production by intact modulated secondary granulomas may reflect local chemokine regulation within the granuloma that would allow initial early sequestration of the egg, yet impair further elicitation of leukocytes to the developing granulomas.
Immunohistochemical localization of MIP-lot from intact granulomas, as well as dispersed granuloma cells, has identified the macrophage as the primary cellular source of MIP-lc~. This corroborates previous in vitro studies showing the macrophage as the predominant cellular source of MIP-lc~ (5). In addition, the dispersion of the vigorous granulomas demonstrated little detectable MIP-lot production by the nonadherent lymphocytes and eosinophils. The fact that MIP-lot could be detected by immunohistochemical localization within granulomas at all stages of infection indicates that this chemokine is involved to a greater or lesser degree in the development of both primary and secondary granulomas.
The contribution of MIP-lot to primary granuloma for- mation was demonstrated by a significant reduction (>40%) of lesion area with anti-MIP-loe serum treatment. In vivo depletion of MIP-lot in 8-wk-infected, vigorous stage mice decreased granuloma area by more than 20%, demonstrating at least a partial role in secondary granuloma formation. The failure of anti-MIP-loe to impair modulated granulomas is consonant with their impaired MIP-lc~ production in response to SEA and supports the notion that MIP-lc~ is downregulated at the modulated stage. There may be several reasons why the anti-MIP-lc~ treatment had less effect on the vigorous lesions. The vigorous granulomas produced significantly more MIP-lo~ than did the primary lesions, and there may have been insufficient neutralization of the MIP-lc~ at this stage. A second explanation may entail the production of other chemotactic factors during the development of secondary modulated granulomas which would allow the granulomatous response to continue at a reduced level. Chemokines, such as murine JE (18) and RANTES (19) , which are both chemotactic for mononuclear cells, may be more prevalent during secondary granuloma formation. Finally, the type and level of chemokines produced during the various stages of granuloma formation may prove to be pertinent to the specific population of cells recruited to the granuloma. The primary granuloma is characterized by the presence of predominantly mononuclear cells. However, with the development of the secondary granuloma, there is a rapid shift in cellular constituents from mononuclear to predominantly eosinophils. The decreased presence of macrophages in the secondary vigorous granuloma may be indicative of the decreased role for MIP-lo~ in monocyte recruitment as reflected by the reduced inhibitory effect of the anti-MIP-lc~ antiserum treatment.
Our findings show that MIP-lc~ is produced in both the early recruitment and maintenance phases of primary and secondary granuloma formation and is therefore a likely contributor to cellular recruitment throughout the growth of the granuloma. The role of MIP-lol production in the granuloma may not only be limited to cellular recruitment, but may also involve the generation of other inflammatory cytokines, IL-1, IL-6, and TNF-ot (5) . The production of MIP-lol within the granuloma may result in increased cytokine production along with local macrophage proliferation and activation. TNF has recently been shown to restore granuloma formation in SCID mice (20) . Therefore, the increased production of TNF in response to MIP-lol could promote granuloma formation during the maintenance phase when TNF production has previously been detected (8) .
The present study provides the first evidence that MIP-lol has an important role in vivo during granuloma formation. The presence of MIP-lot within the granuloma may serve as a monocyte chemotaxin as well as an activating factor for infiltrating leukocytes. It is interesting that our study also suggests that the regulation of chemokines such as MIP-loL may be responsible for determining the degree and rate of granuloma formation.
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